Tandem Diabetes Care (TNDM) Share-based Compensation (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Share-based Compensation came in at $15.7 million in Q1 2026, down 38.56% YoY from $25.5 million in Q1 2025, and up 162.74% on a QoQ basis from -$25.0 million in Q3 2025.
Tandem Diabetes Care (TNDM) Share-based Compensation (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Share-based Compensation data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Share-based Compensation fell 38.56% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (down 86.88% YoY) and the FY2025 annual result came in at $26.2 million, down 74.19% from the prior year.
- Share-based Compensation grew to $15.7 million in Q1 2026, from -$25.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $92.4 million in Q2 2022 to a low of -$50.0 million in Q3 2022.
- A 5-year average of $19.8 million and a median of $22.3 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation slumped 289.8% — and 2025, when it surged 1011.12%.
- Tracing TNDM's Share-based Compensation over 5 years: stood at $24.4 million in 2022, then soared by 260.36% to $88.1 million in 2023, then gained by 4.85% to $92.4 million in 2024, then plunged by 127.03% to -$25.0 million in 2025, then surged by 162.74% to $15.7 million in 2026.
- The last three Share-based Compensation figures came in at $15.7 million (Q1 2026), -$25.0 million (Q3 2025), and $25.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 15.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.74 Mn |
| Jun 30, 2026 | 15.74 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Sep 30, 2025 | -24.96 Mn |
| Sep 30, 2025 | -24.96 Mn |
| Jun 30, 2025 | 25.64 Mn |
| Jun 30, 2025 | 25.64 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Dec 31, 2024 | 92.35 Mn |
| Dec 31, 2024 | 92.35 Mn |
| Sep 30, 2024 | -37.90 Mn |
| Sep 30, 2024 | -37.90 Mn |
| Jun 30, 2024 | 44.64 Mn |
| Jun 30, 2024 | 44.64 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Dec 31, 2023 | 88.08 Mn |
| Dec 31, 2023 | 88.08 Mn |